Stock listing

OTC:MBCI MabCure, Inc. Stock

Follow MabCure, Inc. into a list and get an email when it puts out news.

Share price · OTC:MBCI

$0.0001 USD 0.0000 (0.0%)

Close on Nov 16, 2026

Past year 0.0% · daily closes, Nov 17, 2025 – Nov 16, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDNov 16, 2026
Market cap
—Left out: price × shares is far from the company's reported size
52-week range
$0.0001 – $0.0005 USDLowest and highest trades, Nov 17, 2025 – Nov 16, 2026
Traded on an average day
$9 USDMedian day 0 shares · 29 days with no trades · last 3 months, Aug 17, 2026 – Nov 16, 2026
MabCure, Inc. logo

Daily closes

Last 3 months, Aug 17, 2026 – Nov 16, 2026 · OTC:MBCI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0003-75.0%$0.0001$0.0001$0.000115,000
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.00040.00000.0%$0.0004$0.0004$0.00040
$0.0004-0.0001-20.0%$0.0004$0.0004$0.0004125
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00055,000
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.0005200
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.00050.00000.0%$0.0005$0.0005$0.00051,400
$0.00050.00000.0%$0.0001$0.0005$0.00013,300
$0.00050.00000.0%$0.0005$0.0005$0.00050
$0.0005+0.0003+150.0%$0.0005$0.0005$0.0005241
$0.0002+0.0001+100.0%$0.0002$0.0002$0.00025,000
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001100
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000110,032
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.0001-0.0002-66.7%$0.0005$0.0005$0.0001250
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00031,243,248
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
Ticker
OTC:MBCI
Asset type
Stock
Exchange
OTC
Currency
USD

Valuation

price Nov 16, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
1.56

Financials

Annual, in USD

Income statement

LineFY2011FY2010FY2009FY2008FY2007FY2006
Revenue500.0K000
Cost of revenue0000
Gross profit500.0K000
Research and development390.6K352.0K402.7K3.81K
Selling, general and administrative819.1K667.4K730.2K528.3K
Operating income-709.7K-1.02M-1.36M-536.0K-106.3K-4.00K
Depreciation and amortization32.7K43.1K39.8K4.05K
EBITDA-677.1K-976.3K-1.32M-531.9K
Interest expense186.7K206.9K16.7K970
Income before tax-12.3M-1.23M-1.37M-530.5K
Income tax186.7K206.9K16.7K970106.3K4.00K
Net income-12.5M-1.43M-1.39M-531.5K-106.3K-4.00K
Earnings per share, basic-0.20-0.02-0.02-0.01-0.00-0.00

Balance sheet

LineFY2011FY2010FY2009FY2008FY2007FY2006
Cash and equivalents146.4K3.42K214.5K811.4K45.0K
Receivables44.9K31.9K10.6K
Current assets159.2K56.2K278.1K838.6K51.0K
Property, plant and equipment41.9K123.9K169.7K166.2K
Total assets4.81M16.2M18.9M19.5M51.0K
Accounts payable630.2K286.0K152.3K97.0K4.00K
Current liabilities935.1K466.2K776.2K194.9K49.3K
Long-term debt16.3K56.9K
Total debt261.2K185.8K651.4K181.3K
Total liabilities935.1K482.5K833.0K286.5K49.3K
Shareholders' equity3.88M15.7M18.1M19.2M-49.3K51.0K
Shares outstanding63.7M62.1M60.4M43.1M49.7M7.74M

Cash flow

LineFY2011FY2010FY2009FY2008FY2007FY2006
Cash from operations-61.4K-691.8K-1.03M-455.1K-90.3K-6.00K
Capital spending-1.26K-14.0K-44.4K-170.2K00
Free cash flow-62.7K-705.8K-1.08M-625.3K-90.3K-6.00K
Cash from investing53.2K-14.0K-44.4K-170.2K
Cash from financing166.8K503.4K491.3K1.44M45.3K51.0K
Share buybacks15.8K500.0K500.0K1.30M
Change in cash143.0K-211.1K-597.0K811.4K-45.0K45.0K

Open Financials

Cap table

Built by 6ix from MabCure, Inc.’s releases

Common shares
781,087
Fully diluted
781,087

Fully diluted

LineShares
Common shares781,087

Share count over time

CountShares
Nov 22, 2026781,087

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gad Berdugo
Other companies: Immune Pharmaceuticals Inc (CFO & SVP · Jun 3, 2014 – May 8, 2015 · Past)
Director · Sep 24, 2010 – May 19, 2011 · Past
Ron Kalfus
Other companies: MDxHealth SA (Chief Financial Officer · Since at least Mar 18, 2026)
CFO, Secretary and Treasurer · Dec 1, 2008 – May 19, 2011 · Past
Charles Thomas TackneyChief Scientific Officer · May 19, 2011 – May 19, 2011 · Past
Elisha OrrExecutive VP CSO · Jul 7, 2008 – Jul 7, 2008 · Past

Open People

Log in to ask 6ix AI your own questions about MabCure, Inc.